Journal Article

Lymphatic filariasis elimination status: Wuchereria bancrofti infections in human populations and factors contributing to continued transmission after seven rounds of mass drug administration in Masasi District, Tanzania

Lupenza, Eliza T., Gasarasi, Dinah B., Minzi, Omary M.

2022

Overview

Lymphatic filariasis (LF) affects more than 120 million people globally. In Tanzania, nearly six million people are estimated to live with clinical manifestations of the disease. The National LF control program was established in 2000 using Mass drug administration (MDA) of Ivermectin and Albendazole to individuals aged 5years and above. This study assessed the infection status in individuals aged 15 years and above who are eligible for participation in MDA. The level of compliance to MDA and the reasons for non-compliance to MDA were also assessed. A community based cross-sectional study was conducted in two villages of Masasi District. A total of 590 participants aged 15 years and above were screened for the circulating filarial antigen (CFA) using the rapid diagnostic test. Night blood samples from CFA positive individuals were further analyzed for detection and quantification of Wuchereria bancrofti microfilaria (Mf) using the counting chamber technique. A pre-tested questionnaire was administered to collect information on compliance to MDA and the factors affecting continued transmission. Data were analyzed using SPSS Version 20. Chi-square test was used to compare the prevalence of CFA by gender and village where a P-value ≤0.05 was considered statistically significant. Out of 590 participants, 30 (5.1%) were positive for CFA and one (0.2%) was found positive for microfilaria of Wuchereria bancrofti. Compliance during the last round of MDA, in the year 2019 was 56% which is below the minimum coverage recommended by WHO. Absence from home during MDA and perceptions of being free from hydrocele or elephantiasis were the major reasons for non-compliance. There is a significant decline in LF transmission in Masasi District after seven rounds of MDA. However, the presence of individuals who are persistently non-compliant may delay elimination of LF in the District.

• Publisher: Public Library of Science,Public Library of Science (PLoS)
• Subject: Adolescent / Adult / Aged / Albendazole / Albendazole - therapeutic use / Animals / Antigens / Antigens, Helminth - therapeutic use / Biology and Life Sciences / Blood circulation / Causes of / Chemotherapy / Chi-square test / Community / Cross-Sectional Studies / Disease control / Disease Eradication - methods / Disease transmission / Distribution / Drug therapy / Elephantiasis, Filarial - drug therapy / Elephantiasis, Filarial - epidemiology / Elephantiasis, Filarial - transmission / Entomology / Female / Filariasis / Filaricides - administration & dosage / Filaricides - therapeutic use / Human populations / Humans / Infections / Ivermectin / Ivermectin - therapeutic use / Lymphatic diseases / Male / Mass Drug Administration - methods / Medicine and Health Sciences / Middle Aged / Parasitology / People and Places / Pharmacy / Prevalence / Public health / Social sciences / Statistical analysis / Statistical methods / Statistical tests / Tanzania - epidemiology / Tropical diseases / Vector-borne diseases / Villages / Wuchereria bancrofti / Wuchereria bancrofti - pathogenicity